Enveric Biosciences

ENVBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.244 M

$1.55 -0.64%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

$12.1M

#2014 by earnings

Shares outstanding

1,887,535

Latest filing cover page

P/E ratio

0.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#459Apimeds Pharmaceuticals USAPUS$6.38M
#460Aptevo TherapeuticsAPVO$6.35M
#461Enveric BiosciencesENVB$6.24M
#462HCW BiologicsHCWB$6.19M
#463NuCanaNCNA$6.12M

Where these numbers come from

Share counts and financials for Enveric Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.